• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says
next post
J&J reaches sweeping talc deal that could end decade of litigation

related articles

Cruz says winning AI race against China is...

September 26, 2026

US, China strike deal to lower tariffs on...

September 26, 2026

Dem House hopeful endorsed by activist who said...

September 26, 2026

Trump claims stunning casualty numbers in Russia-Ukraine war

September 26, 2026

Unearthed: El-Sayed called for repealing law that made...

September 25, 2026

Trump to usher in ‘golden age’ of American...

September 25, 2026

Xi’s 100K invitation to America’s youth sets off...

September 25, 2026

Trump scores Supreme Court win in election integrity...

September 25, 2026

‘Squad’ Democrat slammed by Trump admin for most...

September 25, 2026

Frontline NATO ally shares shocking take on Russian...

September 25, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Why is Nvidia stock up over 4% today?

    September 2, 2026
  • Nikkei 225 retreats as Asian markets weigh BOJ, Fed and US-Iran deal

    June 16, 2026
  • BlackRock Q2 earnings preview: What Wall Street expects from BLK stock

    July 14, 2026
  • AI memory chip boom turns into a pay bonanza for Micron, Samsung, SK Hynix workers

    September 11, 2026
  • Nikkei 225 Index analysis as Japan bond yields surge, Softbank stock plunges

    September 2, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (671)
  • Investing (1,507)
  • Stock (90)

Latest Posts

  • Wall Street futures trade flat today: 5 things to know before the market opens

    September 23, 2026
  • Blue state mayor arrested for fraud sparks uproar for not speaking English in viral clip: ‘How is this real’

    August 18, 2026
  • Lucid Group stock has crashed amid bankruptcy fears: Is it safe to buy the dip?

    July 15, 2026

Recent Posts

  • Backblaze jumps 30% on $335M CoreWeave AI storage deal

    June 23, 2026
  • Harvard tops nation in foreign cash haul as Cotton demands probe into China funding

    July 27, 2026
  • SpaceX stock: prediction markets suggest it will fail to hit key milestone by 2030

    June 15, 2026

Editor’s Pick

  • Iran’s regime spins nuclear and Strait of Hormuz deal with Trump as victory over US, Israel

    June 15, 2026
  • Dow falls 500 points as Fed’s hawkish shift jolts markets

    June 17, 2026
  • Kioxia stock is stuck in a bear market: here’s why it may drop further soon

    September 14, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock